IP Library Granted Patent US 8,110,373
Granted Patent B2
US 8,110,373 · App. 12/504,826 · Granted Feb 7, 2012

Methods and compositions for treating and diagnosing diseases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,110,373
App. No.
12/504,826
Granted
Feb 7, 2012
Kind
B2
Abstract

Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.

Claims (5)

1. A method of diagnosing breast cancer in an individual, the method comprising detecting an elevated level of Na—K ATPase beta3 protein in a sample from the individual relative to a control Na—K ATPase beta3 protein level of a non-cancerous sample, wherein the elevated level of Na—K ATPase beta3 protein indicates that said individual has breast cancer.

2. The method of claim 1 , wherein the amino acid sequence of the Na—K ATPase beta3 protein comprises a sequence selected from the group consisting of SEQ ID NOS:127-134.

3. The method of claim 1 , wherein the amino acid sequence of the Na—K ATPase beta3 protein consists of a sequence selected from the group consisting of SEQ ID NOS:127-134.

4. The method of claim 1 , wherein the elevated level of Na—K ATPase beta3 protein is detected by contacting the sample from the individual with an isolated antibody that selectively binds to the Na—K ATPase beta3 protein and detecting binding of the antibody to the Na—K ATPase beta3 protein.

5. The method of claim 4 , wherein the antibody is coupled to a detectable substance.